|

Autologous Tumor Membrane Vesicles Vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Autologous TDMV-derived Vaccine, Autologous TMV Vaccine, Autologous TMV-based Vaccine, Autologous Tumor-derived Membrane Vesicles Vaccine

Pipeline

Phase 1: 1

Top Sponsors

  • Emory University1

Indications

  • Stage IV Sinonasal Cancer AJCC v81
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v81
  • Stage IV Nasopharyngeal Carcinoma AJCC v81
  • Stage IV Lip and Oral Cavity Cancer AJCC v81
  • Stage IV Laryngeal Cancer AJCC v81

Atlanta, Georgia1 trial

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Emory University Hospital Midtown

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.